Burzynski Research Institute

Burzynski Research Institute (BRI ) is a biotech company based in Houston, Texas U.S.A. engaged in research and development of targeted gene therapies (antineoplastons) for the treatment of cancer. The company was formed in 1983 by Stanislaw R. Burzynski, M.D., Ph.D., who continues to serve as Chairman of the Board and C.E.O.

Contact Details: 9432 Old Katy Road, Suite 200 Houston 77055 United States of America Tel: (713) 335-5696 Fax: (713) 935-0649 Email: info@burzynskiresearch.com WWW: www.burzynskiresearch.com/

Recent Publications by Burzynski Research Institute :
The present state of antineoplaston research (1). Antineoplastons work as molecular switches, which regulate expression of...	28th April, 2004	Burzynski Research Institute, Houston, TX 77055, USA.	Integr Cancer Ther. 2004 Mar;3(1):47-58. DOI Direct Link

Burzynski Research Institute Clinical Trials:
Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Burzynski Research Institute (BZYR.OB) Financial information Links from Barchart
BZYR.OB Quote from from Barchart.com
BZYR.OB Chart from from Barchart.com
BZYR.OB Profile from from Barchart.com
BZYR.OB Opinion from from Barchart.com
→View more Burzynski Research Institute finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 243 times since April 2007, the link to the organisation's website has been followed 40 times

Search for more companies in Houston

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Burzynski Research Institute